lipoxin a4 has been researched along with Sarcoma, Kaposi in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marginean, A; Sharma-Walia, N | 1 |
| Chandrasekharan, JA; Huang, XM; Hwang, AC; Sharma-Walia, N | 1 |
2 other study(ies) available for lipoxin a4 and Sarcoma, Kaposi
| Article | Year |
|---|---|
Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cyclooxygenase 2; Down-Regulation; Endothelial Cells; Humans; Inflammation Mediators; Lipoxins; Models, Biological; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Receptors, Lipoxin; Sarcoma, Kaposi; Transcription Factors; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Topics: Adaptor Proteins, Signal Transducing; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cell Line; CRISPR-Cas Systems; Cyclooxygenase 2; Endothelial Cells; Gene Expression Regulation; Herpesvirus 8, Human; Host-Pathogen Interactions; Humans; Inflammation; Lipoxins; Lymphoma, Primary Effusion; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Proto-Oncogene Proteins c-akt; RNA, Viral; Sarcoma, Kaposi; Signal Transduction | 2016 |